Company Overview of Avigo Capital Partners
Avigo Capital Partners is a private equity firm specializing in growth capital, middle market, buyouts, and acquisition financing. The firm seeks equity investments in growth stage companies. It seeks to invest in small and medium enterprises. The firm prefers to invest in industrial, industrial manufacturing, industrial services, engineering, infrastructure, education, media, healthcare, and rural businesses. It seeks to invest in emerging sectors in emerging markets mainly India. The firm typically invests between $2 million and $20 million including follow-on investments in companies with annual revenues above $15 million. Avigo Capital Partners was formed in September 2003 and is based i...
DLF Place (Office Tower)
A-4, District Center
New Delhi, 110017
Founded in 2003
Key Executives for Avigo Capital Partners
Founder, Chief Executive Officer, Managing Partner, and Managing Director
Founder, Managing Director, and Partner
Vice President of Legal and Finance
Compensation as of Fiscal Year 2015.
Avigo Capital Partners Key Developments
Baring Asia, Other PE’s Reportedly In Talks To Buy Stake In SRL Diagnostics
Feb 19 16
Baring Private Equity Asia, Capital International and Bain Capital, LP are reportedly in advanced talks to buy a controlling stake in SRL Diagnostics Private Limited, said people familiar with the matter. SRL Diagnostics had roped in Moelis & Company (NYSE:MC) to advise on a $200-million share sale. "The mandate is for the sole purpose of providing an exit to the PE investors in SRL, holding approx 31% of SRL. Given the strong demand in the space a number of players have evinced keen interest and we are in dialogue," said Sanjeev Vashishta, Chief Executive Officer, SRL in an emailed response. International Finance Corporation, NYLIM Jacob Ballas Capital India and Avigo Capital Partners together own 34% of the company. Fortis Healthcare Limited (BSE:532843) owns about 57% stake while promoters hold the remaining equity in SRL Diagnostics Even though the stake sale mandate was primarily for a minority stake, people in the know said the company was open to all strategic options, including relinquishing control. "The interested buyers have put in two bids each to acquire 34% and 51% stake if the promoters also sell part of their stake. The majority of the interest is to have a controlling stake in the company," said a person involved in the process. One of the people mentioned above said Bain Capital is the frontrunner among the three shortlisted candidates, but this couldn't be independently verified. Email queries sent to spokespersons of SRL Labs, Capital International, Bain Capital and Barings Asia did not elicit any response till the time of going to press.
SRL Diagnostics In Talks With Top PE Funds For 34% Stake Sale
Jan 14 16
SRL Diagnostics Private Limited is in talks with top PE funds for a sale of 34% stake. KKR & Co. L.P., Warburg Pincus LLC and Baring Private Equity Asia have shown interest in buying the 34% stake held by existing investors, according to two persons familiar with the matter who asked not to be identified. These investors include International Finance Corporation (IFC), NYLIM Jacob Ballas Capital India and Avigo Capital Partners. Besides KKR, Warburg and Baring, three other global funds have evinced interest in SRL, one of the person cited in the first instance added, without taking names. The second person added another name—Bain Capital. A spokesperson for Bain Capital declined comment. Spokespersons for KKR, Warburg Pincus, Baring Asia PE and SRL Diagnostics declined comment. Spokespersons for Avigo Capital and Jacob Ballas also declined comment. A spokesperson for IFC didn’t respond to an email seeking comment. Investment bank Moelis is advising SRL on the stake sale.
SRL Diagnostics Reportedly May See Exit Of PE Investors Avigo Capital, Jacob Ballas And IFC
Nov 26 15
Avigo Capital Partners, NYLIM Jacob Ballas India Fund III, LLC and International Finance Corporation are likely to sell their stake in SRL Diagnostics Private Limited, two people familiar with the matter said.
Similar Private Companies By Industry
Recent Private Companies Transactions